Rides
RCC SUMMITS
RCC Summits are journeys in the world’s most beautiful riding destinations. Fully-supported with expertly crafted routes matched with immersive cultural experiences alongside members from around the globe. The apex of our riding year.
Past Forward: The Exhibition
The Past Forward Exhibition explored the moments and ideas that defined Rapha, as well as looking forward to what the future of cycling could hold.
Up the Road
A prelude to 2024
This Is How We Ride
For too long, we have been an afterthought: pushed aside and made to wear kit that limited our self-expression, and restricted how we love to ride. We’ve been left out of races, undervalued and underestimated. It’s about time for change.
Lael's Ride Around the World
This summer Lael Wilcox departs Chicago on May 26th, and sets out to ride non-stop around the world. Follow her dot and get updates here as well as on @rapha, as we track her progress in real time.
Past Forward
Celebrating 20 years of performance, progress and panache.
Embrace the Heat
Crossing the Mojave. It began with a mission to put our hottest weather riding apparel to the ultimate test — crossing the Mojave Desert in a day. A barren, windswept, and sand-blasted desert that sits between LA and Las Vegas. Yet when you enter this desert you feel closest to nowhere.
Women's 100
Returning 13 + 14 September 2025. More than words, more than an event, more than just a ride. The Women’s 100 is a global movement. This year, we’re celebrating with a special edition capsule in collaboration with renowned graphic artist Kelly Anna, launching this July.
Boulder FAR
FAR. Our new ride series that embodies everything we love about riding with the RCC. You, your riding crew and an incredible route. It’s as simple as that.
Migration
Rapha Films presents Migration, a documentary about the Migration Gravel Race and Team AMANI.
Rapha FAR
Days to discover your limits, and keep going.
One More City
One More City is an annual riding challenge between two cities, supporting groundbreaking research into secondary breast cancer.